⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Global Oligonucleotide Therapeutics Market Set to Surge to USD 17.70 Billion by 2030 | MarketsandMarkets™
globenewswire.com
BIIB
ALNY
SRPT
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™
prnewswire.com
BIIB
CHRW
Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms
accessnewswire.com
ABBV
BMY
JNJ
LLY
NVS
REGN
BIIB
Biogen Announces Board Chair Transition
globenewswire.com
BIIB
ARE
EXEL
5G in Healthcare Market to Surge to US$ 808.40 Billion by 2033 Driven by Telehealth Expansion, Remote Patient Monitoring, and Robotic Surgery | Astute Analytica
globenewswire.com
BIIB
WearOptimo to Host Webinar on the Future of Wearables for Precision Health Monitoring
prnewswire.com
BIIB
$12 Bn Private LTE/5G Network Market Forecasts, 2025-2026 & 2030: Insights from 35 New Executive Interviews with Market Leading Companies
globenewswire.com
ERIC
NOK
MSFT
AMZN
SWKS
AVGO
QCOM
INTC
CSCO
HPE
SNPS
AMAT
LRCX
KLAC
ASML
MU
WDC
SE
NVDA
AMD
MRVL
NXPI
QRVO
ON
ADI
TXN
MCHP
INFY
IBM
ORCL
SAP
ACN
CTAS
CDNS
GLW
AVNT
ATOS
NTES
BABA
JD
PDD
IQ
BIDU
HTHT
BILI
VIPS
NIO
LI
XPEV
RIVN
LCID
TSLA
F
GM
STLA
CHPT
PLTR
SNOW
DDOG
CRM
NOW
PANW
FTNT
ZS
CRWD
MDB
PYPL
COIN
UPST
SOFI
AFRM
HOOD
ETSY
GOOG
HPQ
DELL
SMCI
ALGN
IDXX
REGN
VRTX
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
BIIB
AZN
SNY
TEVA
BMRN
EXPE
BKNG
MAR
H
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
DAL
UAL
LUV
BA
GD
LMT
RTX
HON
CAT
DE
GE
MMM
ROK
EMR
ILMN
MELI
ADBE
GOOGL
AAPL
T
VZ
TMUS
CMCSA
CHTR
Idiopathic Pulmonary Fibrosis Market Poised to Reach US$ 6,736.49 Million by 2035 as Late-Stage Pipelines and Novel Mechanisms Transform Treatment Outcomes | Astute Analytica
globenewswire.com
BIIB
GILD
UTHR
Total Lab Automation Research Report 2026: Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2025-2031
globenewswire.com
TMO
DHR
ABT
BIIB
QGEN
HOLX
TECH
HPE
IBM
MSFT
GOOG
AMZN
NVDA
AMD
INTC
ROK
HON
GE
XRAY
ETR
BKR
HAL
SLB
LMT
GD
BA
RTX
CAT
DE
MMM
AVGO
ADSK
CSCO
ACN
ORCL
SAP
CRM
NFLX
DIS
CMCSA
VZ
T
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
VRTX
LRCX
ASML
MU
WDC
EXAS
ILMN
MDLZ
KO
PEP
SBUX
MCD
NKE
TGT
WMT
HD
LOW
COST
MGM
LVS
WYNN
MAR
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China USA - English USA - English
prnewswire.com
BIOA
BIIB